Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Fast Facts Oncology is a must listen for busy clinicians, allowing them to get quickly up-to-speed on the latest developments from the field.
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Updates in the Treatment of Patients with EGFR Exon 20 Insertion Mutation NSCLC
10:17
10:17
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
10:17
This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understandi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S4 E3 - Courtney DiNardo, MD MSCE – Perspectives on AML
30:08
30:08
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
30:08
This is the third episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. DiNardo discusses the missing pieces of MDS management, starting with the latest approvals in MDS treatment and how eligibility for clinical trials is assessed.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S4 E2 - Elizabeth Griffiths, MD – Real World Evidence in Myelodysplastic Syndromes
40:22
40:22
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
40:22
This is the second episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. Griffiths discusses what makes Real World Evidence and how it is obtained or archived, the risk stratification of MDS and what that means for gathering evidenc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S4 E1 - Zachariah DeFilipp, MD – Emerging Treatment Paradigms in Myelodysplastic Syndromes
22:21
22:21
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
22:21
This is the first episode in our series on myelodysplastic syndromes which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. DeFilipp outlines the current and upcoming treatments for myelodysplastic syndromes. He discusses doublet and triplet combinations that are moving the needle on disea…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S3 E3 - Melinda Bachini – Testing in Cholangiocarcinoma – Breaking Down Barriers
18:22
18:22
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
18:22
This is the third episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Melinda Bachini discusses the use of biomarker testing in cholangiocarcinoma. From the perspective of a patient advocate, she explains how to relay complex information about bioma…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S3 E2 - Marina Baretti, MD – Management of Safety When Using FGFR inhibitors
29:27
29:27
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
29:27
This is the second episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Dr. Marina Baretti discusses the safety of fibroblast growth factor receptor (FGFR) inhibitors, drawing from her clinical experience. She details current safety data, and explain…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S3 E1 - Sameek Roychowdhury, MD PhD – FGFR inhibitors: Mechanism and Activity on Resistance Mutations
21:10
21:10
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
21:10
This is the first episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Dr. Sameek Roychowdhury discusses fibroblast growth factor receptor (FGFR) inhibitors in the management of cholangiocarcinoma—how long they’ve been in use, and what we know about …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S2 E3 - Ben George, MD – Perspectives on Real-World Data in Metastatic Colorectal Cancer
16:34
16:34
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
16:34
This is the third episode in our series on colorectal cancer which aims to update clinicians on the latest developments in the management of colorectal cancer. In this episode, Dr. Ben George discusses the importance of real-world data in managing metastatic colorectal cancer care outcomes, and the inescapable truths of daily life that impact patie…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S2 E2 - Reetu Mukherji, MD – Unmet Needs in Metastatic Colorectal Cancer
32:35
32:35
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
32:35
This is the second episode in our series on colorectal cancer which aims to update clinicians on the latest developments in the management of colorectal cancer. In this episode, Dr. Reetu Mukherji discusses unmet needs in the treatment landscape of colorectal cancer. She explains where the greatest needs are in current management, and what research…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S2 E1 - Arvind Dasari, MD MS – Emerging Treatments in Colorectal Cancer
43:48
43:48
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
43:48
This is the first episode in our series on colorectal cancer which aims to update clinicians on the latest developments in treatment. In this episode, Dr. Arvind Dasari starts by explaining the current management of colorectal cancer, and then outlines the latest developments in immunotherapy and targeted therapies, touching on specific trials pres…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E8 - Dr Hope Rugo – ESMO 2022 – Exploring the Latest Trial Data and Advances in Breast Cancer Treatments
35:56
35:56
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
35:56
Welcome to the third episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer we speak with Dr Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr Rugo summarizes the TROPICS02 trial that she…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E7 - Dr Shaheenah Dawood – ESMO 2022 – Clinical Trial Updates in Breast Cancer Management
13:39
13:39
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
13:39
Welcome to the second episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer, we speak with Dr Shaheenah Dawood, a practicing medical oncologist from Dubai, United Arab Emirates. Dr Dawood discusses the MONARCH3 trial – its background, recent findings and how it differs from the MONARCHER trial. Coverage is al…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E6 - Dr Chetan Deshmukh – ESMO 2022 – The Latest Updates in Colorectal Cancer
22:18
22:18
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
22:18
Welcome to the first episode in a three-part special live from ESMO 2022. In this episode focused on colorectal cancer, we speak with Dr Chetan Deshmukh, a practicing medical oncologist from Pune, India. Dr Deshmukh discusses the results from the CARIO5 study, which have been presented at the congress. He also shares with us his thoughts on the pro…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E5 – Breast Cancer Awareness with Abeda Steenkamp from CANSA
24:08
24:08
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
24:08
The fifth and final episode of our special series on breast cancer for Karger’s Fast Facts Oncology Podcast. In episode we are joined by Abeda Steenkamp, breast cancer survivor and Service Coordinator for the Cancer Association of South Africa. Join us as we talk about stigma and taboos surrounding breast cancer in South Africa (CANSA). Furthermore…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E4 – Are Advances in Breast Cancer Treatment Really a Boon for Patients with Dr Omar
27:49
27:49
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
27:49
The fourth episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Omar Hamid from Nairobi Kenya. Dr Omar is a clinical oncologist and passionate advocate for affordable cancer care. Listen in as we discuss whether advances in breast cancer treatment are really a boon for patient…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E3 – Part 2: Changing Landscape in Managing Breast Cancer Patients with Dr Dawood
25:06
25:06
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
25:06
The third episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are again joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, for the second part of our discussion on the ‘changing landscape in managing breast cancer p…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E2 – Part 1: Changing Landscape in Managing Breast Cancer Patients with Dr Dawood
18:52
18:52
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
18:52
The second episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, to discuss the changing landscape in managing breast cancer patients. To accompany this series on…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S1 E1 – Penetration of Breast Cancer Screening in LMICs with Dr Goncalves
18:33
18:33
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
18:33
The first episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Vinicius Knackfuss Gonçalves from the Hospital São Lucas da PUCRS, in Porto Alegre Brazil to discuss the topic of penetration of breast cancer screening in low middle income countries. To accompany this series on b…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Depression in Patients with Cancer
27:56
27:56
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
27:56
Presenter: Philip R. Muskin MD, MA, DLFAPA Professor of Psychiatry Columbia University Irving Medical Center Senior Consultant in Consultation-Liaison Psychiatry New York-Presbyterian Hospital New York, NY Chronic medical illnesses such as cancer are characterized by a notably increased prevalence of depression. Furthermore, several challenges may …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Optimal Treatment of Metastatic TNBC
29:30
29:30
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
29:30
Presenter: Hope S. Rugo MD Professor of Medicine University of California San Francisco Comprehensive Cancer Center TNBC comprises approximately 15% of newly diagnosed breast cancer cases and is defined by being estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor 2-negative. This breast cancer subt…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm
27:20
27:20
Daha Sonra Çal
Daha Sonra Çal
Listeler
Beğen
Beğenildi
27:20
Presenter: Gail J. Roboz MD Professor of Medicine Director, Clinical and Translational Leukemia Program Weill Medical College of Cornell University New York-Presbyterian Hospital New York, New York, United States This brief program will begin with a review of NCCN Guidelines® Recommendations for the treatment of AML in individuals 60 years of age o…
…
continue reading